-Josep M Ribera Researcher Activity Profile

Research Author Detailed Information 

Josep M Ribera Publication Rate By Year

Josep M Ribera has published 1 paper(s) in 2006, 17 paper(s) in 2007, 6 paper(s) in 2008, for a total of 24 research publications in total.

Josep M Jm Ribera Author Information

LAST NAME: ribera

FIRST NAME: Josep M

INITIALS: jm

AFFILIATION:

Papers

Josep M Ribera's Publication Record

1. Year Published: 2006
2. Response to highly active antiretroviral therapy as the only therapy in an HIV-infected patient with interfollicular Hodgkin's lymphoma. Year Published: 2007
3. Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosis. Year Published: 2007
4. Response to highly active antiretroviral therapy as the only therapy in an HIV-infected patient with interfollicular Hodgkin's lymphoma. Year Published: 2007
5. [Alveolar haemorrhage and HELLP syndrome.] Year Published: 2007
6. [Neutropenic enterocolitis in adult patients with acute leukemia or stem cell transplant recipients: study of 7 cases.] Year Published: 2007
7. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients. Year Published: 2007
8. Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease. Year Published: 2007
9. Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease. Year Published: 2007
10. Advanced Stage Is the Most Important Prognostic Factor for Survival in Patients with Systemic Acquired Immunodeficiency Syndrome-Related Non-Hodgkin's Lymphoma Treated with CHOP and Highly Active Antiretroviral Therapy. Year Published: 2007
11. Response to highly active antiretroviral therapy as the only therapy in an HIV-infected patient with interfollicular Hodgkin's lymphoma. Year Published: 2007
12. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients. Year Published: 2007
13. [Alveolar haemorrhage and HELLP syndrome] Year Published: 2007
14. Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART. Year Published: 2008
15. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients. Year Published: 2007
16. [Neutropenic enterocolitis in adult patients with acute leukemia or stem cell transplant recipients: study of 7 cases] Year Published: 2007
17. Advanced stage is the most important prognostic factor for survival in patients with systemic acquired immunodeficiency syndrome-related non-Hodgkin's Lymphoma treated with CHOP and highly active antiretroviral therapy. Year Published: 2007
18. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial. Year Published: 2008
19. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival. Year Published: 2008
Hospital de la Santa Creu i Sant Pau, Universitat Autonoma Barcelona, Barcelona, Spain. dvalcarcel@santpau.es
20. [Alveolar haemorrhage and HELLP syndrome] Year Published: 2007
21. High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma. Year Published: 2008
Department of Hematology, Hospital Clínic, IDIBAPS, Barcelona, Spain.
22. [Neutropenic enterocolitis in adult patients with acute leukemia or stem cell transplant recipients: study of 7 cases] Year Published: 2007
Servicio de Hematología Clínica. Institut Català d'Oncologia-Hospital Universitari Germans Trias i Pujol. Badalona. Barcelona. España. mbatlle@iconcologia.net
23. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival. Year Published: 2008
Hospital de la Santa Creu i Sant Pau, Universitat Autonoma Barcelona, Barcelona, Spain. dvalcarcel@santpau.es
24. High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma. Year Published: 2008